Teplizumab Antibody

SKU: orb1980680

Description

Teplizumab (MGA-031) is a humanized anti-CD3 monoclonal antibody developed to delay the progression of type 1 diabetes by preserving pancreatic beta cell function. It is utilized in research to investigate immunomodulation, both in vitro and in animal models of autoimmune diabetes.

Research Area

Signal Transduction

Images & Validation

−

Key Properties

−

CAS Number	876387-05-2
MW	145.79 kDa
Purity	99.7% (SEC-HPLC)
Target	Integrin,Others

Bioactivity

−

In Vivo	In NSG mice, Teplizumab (0.24 mg/kg, i.p.) induces migration of human CD4 T cells to the lamina propria and ablates the treatment effects of the drug on graft survival. Read more...
In Vitro	Teplizumab induces human CD8+ T-cell proliferation (10 ng/mL-10 μg/mL, 5 days). Teplizumab increases the expression of CD25 and intracellular CTLA4 on CD8+ cells (freshly isolated PBMCs) after 6 days. Read more...

Storage & Handling

−

Storage	Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Expiration Date	12 months from date of receipt.
Disclaimer	For research use only

Alternative Names

−

MGA-031, CD3, PRV-031

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Quick Database Links

Gene Symbol

Integrin,Others

Documents Download

Datasheet

Product Information

Download

Request a Document

Protocol Information

Find More Protocols